25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Vitrolife AB
Buy, Hold or Sell?

Let's analyze Vitrolife together

I guess you are interested in Vitrolife AB. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Vitrolife AB. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Vitrolife AB

I send you an email if I find something interesting about Vitrolife AB.

Quick analysis of Vitrolife (30 sec.)










What can you expect buying and holding a share of Vitrolife? (30 sec.)

How much money do you get?

How much money do you get?
kr0.16
When do you have the money?
1 year
How often do you get paid?
65.0%

What is your share worth?

Current worth
kr97.70
Expected worth in 1 year
kr69.78
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
kr-26.22
Return On Investment
-11.9%

For what price can you sell your share?

Current Price per Share
kr221.20
Expected price per share
kr196.74 - kr269.86
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

1. Valuation of Vitrolife (5 min.)




Live pricePrice per Share (EOD)

kr221.20

Intrinsic Value Per Share

kr29.75 - kr52.03

Total Value Per Share

kr127.45 - kr149.73

2. Growth of Vitrolife (5 min.)




Is Vitrolife growing?

Current yearPrevious yearGrowGrow %
How rich?$1.2b$1.5b-$119m-8.3%

How much money is Vitrolife making?

Current yearPrevious yearGrowGrow %
Making money-$89.8m$9.6m-$99.5m-110.7%
Net Profit Margin-105.6%12.4%--

How much money comes from the company's main activities?

3. Financial Health of Vitrolife (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#30 / 333

Most Revenue
#77 / 333

Most Profit
#327 / 333

Most Efficient
#243 / 333
3rd party ad coffee SUPPORTERis ad-free.

What can you expect buying and holding a share of Vitrolife? (5 min.)

Welcome investor! Vitrolife's management wants to use your money to grow the business. In return you get a share of Vitrolife.

What can you expect buying and holding a share of Vitrolife?

First you should know what it really means to hold a share of Vitrolife. And how you can make/lose money.

Speculation

The Price per Share of Vitrolife is kr221.20. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Vitrolife.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Vitrolife, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr97.70. Based on the TTM, the Book Value Change Per Share is kr-6.98 per quarter. Based on the YOY, the Book Value Change Per Share is kr2.72 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr0.42 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Vitrolife.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps0.080.0%-0.66-0.3%0.070.0%-0.080.0%-0.020.0%
Usd Book Value Change Per Share0.350.2%-0.65-0.3%0.250.1%0.400.2%0.220.1%
Usd Dividend Per Share0.000.0%0.040.0%0.060.0%0.040.0%0.030.0%
Usd Total Gains Per Share0.350.2%-0.61-0.3%0.310.1%0.440.2%0.250.1%
Usd Price Per Share18.83-17.62-18.64-22.70-26.32-
Price to Earnings Ratio59.18-41.33-67.30-126.19-163.81-
Price-to-Total Gains Ratio53.38--16.38-61.91-89.58-610.16-
Price to Book Ratio2.06-1.72-1.63-8.48-26.61-
Price-to-Total Gains Ratio53.38--16.38-61.91-89.58-610.16-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share20.72644
Number of shares48
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.040.04
Usd Book Value Change Per Share-0.650.40
Usd Total Gains Per Share-0.610.44
Gains per Quarter (48 shares)-29.4921.17
Gains per Year (48 shares)-117.9584.67
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
18-126-12877775
215-251-24615155160
323-377-36422232245
431-502-48230309330
538-628-60037386415
646-754-71844464500
753-879-83652541585
861-1005-95459618670
969-1130-107267695755
1076-1256-119074773840

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%11.01.00.091.7%19.01.00.095.0%39.01.00.097.5%79.02.00.097.5%
Book Value Change Per Share2.02.00.050.0%9.03.00.075.0%16.04.00.080.0%35.05.00.087.5%67.014.00.082.7%
Dividend per Share2.00.02.050.0%10.00.02.083.3%14.00.06.070.0%26.00.014.065.0%35.00.046.043.2%
Total Gains per Share2.02.00.050.0%10.02.00.083.3%17.03.00.085.0%36.04.00.090.0%70.011.00.086.4%
3rd party ad coffee SUPPORTERis ad-free.

Fundamentals of Vitrolife

About Vitrolife AB

Vitrolife AB (publ) provides assisted reproduction products. It also offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. In addition, the company offers EmbryoScope and time-lapse systems; time-lapse dishes; and evaluation tools for time-lapse systems. The company operates in Europe, the Middle East, India and Africa; Asia; Japan and Pacific; Americas; and Asia. Vitrolife AB (publ) was founded in 1994 and is based in Gothenburg, Sweden.

Fundamental data was last updated by Penke on 2024-07-02 06:43:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is fair priced.
3rd party ad coffee SUPPORTERis ad-free.

1.1. Profitability of Vitrolife AB.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Vitrolife earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare¬†Vitrolife to the¬†Medical Devices industry mean.
  • A Net Profit Margin of 13.7%¬†means that¬†kr0.14 for each kr1¬†in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Vitrolife AB:

  • The MRQ is 13.7%. The company is making a huge profit. +2
  • The TTM is -105.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ13.7%TTM-105.6%+119.3%
TTM-105.6%YOY12.4%-118.0%
TTM-105.6%5Y-5.7%-99.9%
5Y-5.7%10Y9.4%-15.2%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ13.7%-11.7%+25.4%
TTM-105.6%-14.9%-90.7%
YOY12.4%-13.3%+25.7%
5Y-5.7%-20.1%+14.4%
10Y9.4%-23.9%+33.3%
1.1.2. Return on Assets

Shows how efficient Vitrolife is using its assets to generate profit.

  • Above 5% is considered healthy¬†but always compare¬†Vitrolife to the¬†Medical Devices industry mean.
  • 0.7% Return on Assets means that¬†Vitrolife generated¬†kr0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Vitrolife AB:

  • The MRQ is 0.7%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is -5.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ0.7%TTM-5.9%+6.6%
TTM-5.9%YOY0.5%-6.4%
TTM-5.9%5Y0.8%-6.7%
5Y0.8%10Y2.7%-1.9%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7%-3.5%+4.2%
TTM-5.9%-3.7%-2.2%
YOY0.5%-3.6%+4.1%
5Y0.8%-3.4%+4.2%
10Y2.7%-4.0%+6.7%
1.1.3. Return on Equity

Shows how efficient Vitrolife is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare¬†Vitrolife to the¬†Medical Devices industry mean.
  • 0.9% Return on Equity means Vitrolife generated kr0.01¬†for each¬†kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Vitrolife AB:

  • The MRQ is 0.9%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is -7.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ0.9%TTM-7.7%+8.5%
TTM-7.7%YOY0.6%-8.3%
TTM-7.7%5Y0.8%-8.5%
5Y0.8%10Y3.3%-2.5%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9%-3.8%+4.7%
TTM-7.7%-3.9%-3.8%
YOY0.6%-4.7%+5.3%
5Y0.8%-5.3%+6.1%
10Y3.3%-5.8%+9.1%
3rd party ad coffee SUPPORTERis ad-free.

1.2. Operating Efficiency of Vitrolife AB.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Vitrolife is operating .

  • Measures how much profit Vitrolife makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare¬†Vitrolife to the¬†Medical Devices industry mean.
  • An Operating Margin of 19.0%¬†means the company generated kr0.19 ¬†for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Vitrolife AB:

  • The MRQ is 19.0%. The company is operating efficient. +1
  • The TTM is 20.6%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ19.0%TTM20.6%-1.6%
TTM20.6%YOY17.4%+3.2%
TTM20.6%5Y24.9%-4.3%
5Y24.9%10Y22.3%+2.6%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ19.0%-28.5%+47.5%
TTM20.6%-12.9%+33.5%
YOY17.4%-12.4%+29.8%
5Y24.9%-19.1%+44.0%
10Y22.3%-22.8%+45.1%
1.2.2. Operating Ratio

Measures how efficient Vitrolife is keeping operating costs low.

  • Below 1 is considered healthy (always compare to¬†Medical Devices industry mean).
  • An Operation Ratio of 0.81 means that the operating costs are kr0.81 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of Vitrolife AB:

  • The MRQ is 0.810. The company is less efficient in keeping operating costs low.
  • The TTM is 0.794. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.810TTM0.794+0.016
TTM0.794YOY0.802-0.008
TTM0.7945Y0.751+0.042
5Y0.75110Y0.722+0.029
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8101.422-0.612
TTM0.7941.432-0.638
YOY0.8021.430-0.628
5Y0.7511.416-0.665
10Y0.7221.380-0.658
3rd party ad coffee SUPPORTERis ad-free.

1.3. Liquidity of Vitrolife AB.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Vitrolife is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to¬†Medical Devices industry mean).
  • A Current Ratio of 3.68¬†means the company has kr3.68 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of Vitrolife AB:

  • The MRQ is 3.683. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.243. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.683TTM3.243+0.441
TTM3.243YOY2.295+0.947
TTM3.2435Y5.260-2.017
5Y5.26010Y4.551+0.709
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ3.6832.643+1.040
TTM3.2432.658+0.585
YOY2.2953.185-0.890
5Y5.2603.651+1.609
10Y4.5513.596+0.955
1.3.2. Quick Ratio

Measures if Vitrolife is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but¬†always compare¬†Vitrolife to the¬†Medical Devices industry mean.
  • A Quick Ratio of 2.86¬†means the company can pay off kr2.86 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Vitrolife AB:

  • The MRQ is 2.863. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.440. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.863TTM2.440+0.424
TTM2.440YOY1.605+0.835
TTM2.4405Y4.341-1.902
5Y4.34110Y3.604+0.738
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.8631.385+1.478
TTM2.4401.494+0.946
YOY1.6051.929-0.324
5Y4.3412.331+2.010
10Y3.6042.577+1.027
3rd party ad coffee SUPPORTERis ad-free.

1.4. Solvency of Vitrolife AB.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Vitrolife assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare¬†Vitrolife to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.22¬†means that Vitrolife assets are¬†financed with 21.6% credit (debt) and the remaining percentage (100% - 21.6%)¬†is financed by its owners/shareholders.¬†

Let's take a look of the Debt to Asset Ratio trends of Vitrolife AB:

  • The MRQ is 0.216. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.200. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.216TTM0.200+0.016
TTM0.200YOY0.188+0.012
TTM0.2005Y0.168+0.032
5Y0.16810Y0.179-0.012
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2160.412-0.196
TTM0.2000.414-0.214
YOY0.1880.344-0.156
5Y0.1680.430-0.262
10Y0.1790.459-0.280
1.4.2. Debt to Equity Ratio

Measures if Vitrolife is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but¬†always compare¬†Vitrolife to the¬†Medical Devices industry mean.
  • A Debt to Equity ratio of 27.5% means that company has kr0.28 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Vitrolife AB:

  • The MRQ is 0.275. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.251. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.275TTM0.251+0.024
TTM0.251YOY0.231+0.019
TTM0.2515Y0.204+0.046
5Y0.20410Y0.224-0.020
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2750.554-0.279
TTM0.2510.599-0.348
YOY0.2310.493-0.262
5Y0.2040.612-0.408
10Y0.2240.682-0.458
3rd party ad coffee SUPPORTERis ad-free.

2. Market Valuation of Vitrolife AB

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Vitrolife generates.

  • Above 15 is considered overpriced but¬†always compare¬†Vitrolife to the¬†Medical Devices industry mean.
  • A PE ratio of 59.18 means the investor is paying kr59.18¬†for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Vitrolife AB:

  • The EOD is 65.132. Based on the earnings, the company is expensive. -2
  • The MRQ is 59.184. Based on the earnings, the company is expensive. -2
  • The TTM is 41.325. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD65.132MRQ59.184+5.948
MRQ59.184TTM41.325+17.859
TTM41.325YOY67.297-25.972
TTM41.3255Y126.191-84.866
5Y126.19110Y163.815-37.623
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD65.132-1.143+66.275
MRQ59.184-1.695+60.879
TTM41.325-1.986+43.311
YOY67.297-2.521+69.818
5Y126.191-2.456+128.647
10Y163.815-1.915+165.730
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Vitrolife AB:

  • The EOD is 46.814. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 42.539. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 38.455. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD46.814MRQ42.539+4.275
MRQ42.539TTM38.455+4.084
TTM38.455YOY41.995-3.539
TTM38.4555Y2,091.285-2,052.830
5Y2,091.28510Y1,179.409+911.876
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD46.814-2.637+49.451
MRQ42.539-3.428+45.967
TTM38.455-2.820+41.275
YOY41.995-5.407+47.402
5Y2,091.285-4.806+2,096.091
10Y1,179.409-5.522+1,184.931
3rd party ad coffee SUPPORTERis ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Vitrolife is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy¬†(always compare to Medical Devices industry mean).
  • A PB ratio of 2.06 means the investor is paying kr2.06¬†for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of Vitrolife AB:

  • The EOD is 2.264. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.057. Based on the equity, the company is underpriced. +1
  • The TTM is 1.719. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.264MRQ2.057+0.207
MRQ2.057TTM1.719+0.338
TTM1.719YOY1.631+0.088
TTM1.7195Y8.481-6.761
5Y8.48110Y26.609-18.128
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD2.2642.103+0.161
MRQ2.0572.244-0.187
TTM1.7192.499-0.780
YOY1.6312.866-1.235
5Y8.4814.135+4.346
10Y26.6094.478+22.131
2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Vitrolife AB compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--3.765-6.981+285%2.719+38%4.295-12%2.379+58%
Book Value Per Share--97.699112.712-13%122.090-20%66.855+46%37.124+163%
Current Ratio--3.6833.243+14%2.295+60%5.260-30%4.551-19%
Debt To Asset Ratio--0.2160.200+8%0.188+15%0.168+29%0.179+20%
Debt To Equity Ratio--0.2750.251+10%0.231+19%0.204+35%0.224+23%
Dividend Per Share---0.425-100%0.615-100%0.411-100%0.318-100%
Eps--0.849-7.080+934%0.760+12%-0.892+205%-0.240+128%
Free Cash Flow Per Share--1.1811.262-6%1.205-2%0.926+28%0.683+73%
Free Cash Flow To Equity Per Share--0.4430.709-38%0.100+344%2.635-83%1.445-69%
Gross Profit Margin---0.470-0.101-78%-0.591+26%-0.225-52%0.010-4837%
Intrinsic Value_10Y_max--52.035--------
Intrinsic Value_10Y_min--29.755--------
Intrinsic Value_1Y_max--4.249--------
Intrinsic Value_1Y_min--2.791--------
Intrinsic Value_3Y_max--13.502--------
Intrinsic Value_3Y_min--8.600--------
Intrinsic Value_5Y_max--23.642--------
Intrinsic Value_5Y_min--14.600--------
Market Cap29960878169.600+9%27224848608.00025467423679.200+7%26940409891.200+1%32816778333.280-17%38051602021.968-28%
Net Profit Margin--0.137-1.056+872%0.124+10%-0.057+142%0.094+45%
Operating Margin--0.1900.206-8%0.174+10%0.249-24%0.223-15%
Operating Ratio--0.8100.794+2%0.802+1%0.751+8%0.722+12%
Pb Ratio2.264+9%2.0571.719+20%1.631+26%8.481-76%26.609-92%
Pe Ratio65.132+9%59.18441.325+43%67.297-12%126.191-53%163.815-64%
Price Per Share221.200+9%201.000188.025+7%198.900+1%242.285-17%280.934-28%
Price To Free Cash Flow Ratio46.814+9%42.53938.455+11%41.995+1%2091.285-98%1179.409-96%
Price To Total Gains Ratio58.747+9%53.382-16.379+131%61.907-14%89.580-40%610.164-91%
Quick Ratio--2.8632.440+17%1.605+78%4.341-34%3.604-21%
Return On Assets--0.007-0.059+971%0.005+34%0.008-14%0.027-75%
Return On Equity--0.009-0.077+982%0.006+39%0.008+9%0.033-73%
Total Gains Per Share--3.765-6.556+274%3.333+13%4.706-20%2.697+40%
Usd Book Value--1239932100.0001430471050.000-13%1549493475.000-20%848487841.050+46%471160801.243+163%
Usd Book Value Change Per Share--0.353-0.654+285%0.255+38%0.402-12%0.223+58%
Usd Book Value Per Share--9.15410.561-13%11.440-20%6.264+46%3.479+163%
Usd Dividend Per Share---0.040-100%0.058-100%0.039-100%0.030-100%
Usd Eps--0.080-0.663+934%0.071+12%-0.084+205%-0.022+128%
Usd Free Cash Flow--14992000.00016022700.000-6%15296525.000-2%11755798.770+28%8662370.573+73%
Usd Free Cash Flow Per Share--0.1110.118-6%0.113-2%0.087+28%0.064+73%
Usd Free Cash Flow To Equity Per Share--0.0420.066-38%0.009+344%0.247-83%0.135-69%
Usd Market Cap2807334284.492+9%2550968314.5702386297598.741+7%2524316406.805+1%3074932129.828-17%3565435109.458-28%
Usd Price Per Share20.726+9%18.83417.618+7%18.637+1%22.702-17%26.323-28%
Usd Profit--10775500.000-89858300.000+934%9651100.000+12%-11322309.775+205%-3040368.230+128%
Usd Revenue--78801700.00081940650.000-4%78145800.000+1%54723531.355+44%37854774.233+108%
Usd Total Gains Per Share--0.353-0.614+274%0.312+13%0.441-20%0.253+40%
 EOD+4 -4MRQTTM+16 -20YOY+21 -155Y+16 -2010Y+19 -17

3.2. Fundamental Score

Let's check the fundamental score of Vitrolife AB based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1565.132
Price to Book Ratio (EOD)Between0-12.264
Net Profit Margin (MRQ)Greater than00.137
Operating Margin (MRQ)Greater than00.190
Quick Ratio (MRQ)Greater than12.863
Current Ratio (MRQ)Greater than13.683
Debt to Asset Ratio (MRQ)Less than10.216
Debt to Equity Ratio (MRQ)Less than10.275
Return on Equity (MRQ)Greater than0.150.009
Return on Assets (MRQ)Greater than0.050.007
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Vitrolife AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5074.415
Ma 20Greater thanMa 50181.505
Ma 50Greater thanMa 100181.246
Ma 100Greater thanMa 200183.037
OpenGreater thanClose224.000
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in SEK. All numbers in thousands.

Summary
Total Assets16,873,000
Total Liabilities3,640,000
Total Stockholder Equity13,231,000
 As reported
Total Liabilities 3,640,000
Total Stockholder Equity+ 13,231,000
Total Assets = 16,873,000

Assets

Total Assets16,873,000
Total Current Assets2,048,000
Long-term Assets14,825,000
Total Current Assets
Cash And Cash Equivalents 947,000
Net Receivables 645,000
Inventory 393,000
Other Current Assets 63,000
Total Current Assets  (as reported)2,048,000
Total Current Assets  (calculated)2,048,000
+/-0
Long-term Assets
Property Plant Equipment 368,000
Goodwill 9,867,000
Intangible Assets 4,403,000
Long-term Assets  (as reported)14,825,000
Long-term Assets  (calculated)14,638,000
+/- 187,000

Liabilities & Shareholders' Equity

Total Current Liabilities556,000
Long-term Liabilities3,084,000
Total Stockholder Equity13,231,000
Total Current Liabilities
Short-term Debt 119,000
Short Long Term Debt 84,000
Accounts payable 164,000
Other Current Liabilities 235,000
Total Current Liabilities  (as reported)556,000
Total Current Liabilities  (calculated)602,000
+/- 46,000
Long-term Liabilities
Long term Debt 1,891,000
Capital Lease Obligations 95,000
Long-term Liabilities  (as reported)3,084,000
Long-term Liabilities  (calculated)1,986,000
+/- 1,098,000
Total Stockholder Equity
Common Stock28,000
Retained Earnings -1,881,000
Accumulated Other Comprehensive Income 1,541,000
Other Stockholders Equity 13,543,000
Total Stockholder Equity (as reported)13,231,000
Total Stockholder Equity (calculated)13,231,000
+/-0
Other
Capital Stock28,000
Cash and Short Term Investments 947,000
Common Stock Shares Outstanding 135,395
Current Deferred Revenue38,000
Liabilities and Stockholders Equity 16,873,000
Net Debt 1,123,000
Net Invested Capital 15,206,000
Net Working Capital 1,492,000
Short Long Term Debt Total 2,070,000



Balance Sheet

Currency in SEK. All numbers in thousands.

 Trend2024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-06-302002-12-312002-06-302001-12-312001-06-302000-06-30
> Total Assets 
116,790
312,222
328,042
292,784
188,515
158,754
183,995
193,055
193,661
192,714
185,538
193,369
205,990
206,727
211,370
280,024
276,381
281,880
271,034
285,361
291,012
295,811
299,460
306,758
317,817
323,243
342,662
351,868
342,141
339,523
359,315
374,309
389,393
388,251
429,388
436,471
442,136
463,004
466,780
473,881
501,471
495,293
462,198
465,841
479,565
467,236
487,808
497,442
505,265
554,346
972,482
960,446
957,279
993,135
1,059,243
1,107,151
1,128,830
1,189,371
1,250,491
1,286,096
1,302,928
1,317,216
1,422,424
1,550,134
1,566,360
1,619,292
1,697,467
1,880,172
1,952,673
2,092,341
2,138,687
2,247,569
2,203,185
2,255,316
2,305,089
2,497,494
2,513,722
6,140,833
19,428,796
19,535,000
19,907,000
20,206,000
20,551,000
20,762,000
21,648,000
21,180,000
16,391,000
16,873,000
16,873,00016,391,00021,180,00021,648,00020,762,00020,551,00020,206,00019,907,00019,535,00019,428,7966,140,8332,513,7222,497,4942,305,0892,255,3162,203,1852,247,5692,138,6872,092,3411,952,6731,880,1721,697,4671,619,2921,566,3601,550,1341,422,4241,317,2161,302,9281,286,0961,250,4911,189,3711,128,8301,107,1511,059,243993,135957,279960,446972,482554,346505,265497,442487,808467,236479,565465,841462,198495,293501,471473,881466,780463,004442,136436,471429,388388,251389,393374,309359,315339,523342,141351,868342,662323,243317,817306,758299,460295,811291,012285,361271,034281,880276,381280,024211,370206,727205,990193,369185,538192,714193,661193,055183,995158,754188,515292,784328,042312,222116,790
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
103,818
0
115,751
118,378
131,563
137,267
133,610
144,556
153,436
164,696
242,131
249,369
142,816
155,863
161,969
161,664
187,325
203,255
213,122
260,255
308,782
301,490
314,634
354,566
414,454
466,823
340,605
397,477
476,519
532,647
562,887
604,247
709,905
757,817
777,613
849,720
850,576
956,480
918,350
1,069,634
1,150,224
1,237,464
1,239,973
1,310,340
1,414,442
1,593,101
1,623,547
5,252,743
1,406,601
1,409,000
1,328,000
1,408,000
1,572,000
1,653,000
1,816,000
1,825,000
1,914,000
2,048,000
2,048,0001,914,0001,825,0001,816,0001,653,0001,572,0001,408,0001,328,0001,409,0001,406,6015,252,7431,623,5471,593,1011,414,4421,310,3401,239,9731,237,4641,150,2241,069,634918,350956,480850,576849,720777,613757,817709,905604,247562,887532,647476,519397,477340,605466,823414,454354,566314,634301,490308,782260,255213,122203,255187,325161,664161,969155,863142,816249,369242,131164,696153,436144,556133,610137,267131,563118,378115,7510103,818000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15,987
0
11,344
9,608
18,617
17,811
10,408
15,516
20,873
26,764
19,115
15,018
11,680
19,309
18,824
30,997
53,769
65,514
70,805
119,274
107,598
90,458
75,648
115,902
199,572
202,333
75,971
118,651
189,245
218,078
235,739
285,055
395,963
399,289
421,397
496,225
490,810
522,078
446,548
599,010
689,538
715,478
753,796
834,256
973,566
1,117,594
1,155,482
4,763,324
630,094
583,000
444,000
461,000
578,000
618,000
687,000
778,000
861,000
947,000
947,000861,000778,000687,000618,000578,000461,000444,000583,000630,0944,763,3241,155,4821,117,594973,566834,256753,796715,478689,538599,010446,548522,078490,810496,225421,397399,289395,963285,055235,739218,078189,245118,65175,971202,333199,572115,90275,64890,458107,598119,27470,80565,51453,76930,99718,82419,30911,68015,01819,11526,76420,87315,51610,40817,81118,6179,60811,344015,987000000000000000000000000000000
       Net Receivables 
18,495
22,871
24,601
25,159
23,055
21,086
13,424
19,615
19,185
18,325
13,244
22,796
24,732
18,669
15,697
32,379
31,671
30,945
28,090
38,151
33,998
33,184
27,410
41,334
43,764
43,657
38,655
52,705
54,071
48,300
38,768
53,593
52,128
48,857
42,830
64,584
67,072
68,637
57,291
68,670
64,164
67,533
58,361
72,457
78,850
67,485
67,275
76,193
81,566
77,858
102,166
112,719
132,999
127,093
104,045
157,780
140,679
143,992
133,514
160,841
178,186
173,145
153,614
194,970
184,818
186,025
189,231
231,637
253,668
242,412
240,179
274,530
218,978
236,751
236,848
248,319
227,707
239,138
463,614
491,000
459,000
433,000
542,000
618,000
680,000
535,000
583,000
645,000
645,000583,000535,000680,000618,000542,000433,000459,000491,000463,614239,138227,707248,319236,848236,751218,978274,530240,179242,412253,668231,637189,231186,025184,818194,970153,614173,145178,186160,841133,514143,992140,679157,780104,045127,093132,999112,719102,16677,85881,56676,19367,27567,48578,85072,45758,36167,53364,16468,67057,29168,63767,07264,58442,83048,85752,12853,59338,76848,30054,07152,70538,65543,65743,76441,33427,41033,18433,99838,15128,09030,94531,67132,37915,69718,66924,73222,79613,24418,32519,18519,61513,42421,08623,05525,15924,60122,87118,495
       Other Current Assets 
0
0
2,399
0
1,466
0
1,534
0
0
0
3,046
0
0
0
3,092
0
0
0
4,199
0
0
0
3,215
0
0
0
6,098
0
0
532
45,984
4,788
56,573
53,941
56,336
67,021
67,383
68,637
66,854
69,438
159,855
171,694
68,727
74,104
78,850
67,485
73,640
76,193
81,566
77,858
109,508
112,719
133,318
127,093
112,598
158,170
140,679
143,992
141,620
160,841
178,186
173,145
163,386
204,142
198,844
196,557
198,580
257,022
282,584
264,225
251,866
287,459
234,810
251,772
1
260,630
243,429
253,681
-1
-1,000
-1,000
1,000
47,000
-1,000
-1,000
60,000
57,000
63,000
63,00057,00060,000-1,000-1,00047,0001,000-1,000-1,000-1253,681243,429260,6301251,772234,810287,459251,866264,225282,584257,022198,580196,557198,844204,142163,386173,145178,186160,841141,620143,992140,679158,170112,598127,093133,318112,719109,50877,85881,56676,19373,64067,48578,85074,10468,727171,694159,85569,43866,85468,63767,38367,02156,33653,94156,5734,78845,984532006,0980003,2150004,1990003,0920003,0460001,53401,46602,39900
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
255,497
0
273,642
269,873
297,825
299,204
308,526
318,448
313,344
309,185
259,340
245,924
319,382
309,978
317,596
305,572
300,483
294,187
292,143
294,091
663,700
658,956
642,645
638,569
644,789
640,328
788,225
791,894
773,972
753,449
740,041
712,969
712,519
792,317
788,747
769,572
846,891
923,692
1,034,323
1,022,707
988,463
1,010,105
963,212
944,976
890,648
904,393
890,177
888,090
18,022,195
18,126,000
18,579,000
18,798,000
18,978,000
19,109,000
19,832,000
19,355,000
14,477,000
14,825,000
14,825,00014,477,00019,355,00019,832,00019,109,00018,978,00018,798,00018,579,00018,126,00018,022,195888,090890,177904,393890,648944,976963,2121,010,105988,4631,022,7071,034,323923,692846,891769,572788,747792,317712,519712,969740,041753,449773,972791,894788,225640,328644,789638,569642,645658,956663,700294,091292,143294,187300,483305,572317,596309,978319,382245,924259,340309,185313,344318,448308,526299,204297,825269,873273,6420255,497000000000000000000000000000000
       Property Plant Equipment 
36,185
67,666
106,370
136,887
94,155
88,979
77,385
81,716
84,425
86,828
83,656
89,721
97,276
88,527
88,802
88,860
85,328
83,677
81,736
82,612
81,333
77,444
76,639
72,137
76,114
86,610
94,802
103,389
98,763
92,990
93,038
91,531
94,142
86,598
91,316
95,209
95,304
97,519
95,444
92,520
101,019
95,957
94,445
93,873
93,005
87,172
85,956
83,878
84,214
85,366
92,322
95,776
91,697
90,271
89,641
87,681
90,533
90,536
93,655
91,517
89,672
84,895
84,432
86,427
91,246
90,440
94,126
174,598
176,168
180,580
173,359
175,747
164,025
154,079
142,113
146,759
160,441
159,451
332,974
347,000
359,000
342,000
318,000
307,000
349,000
353,000
349,000
368,000
368,000349,000353,000349,000307,000318,000342,000359,000347,000332,974159,451160,441146,759142,113154,079164,025175,747173,359180,580176,168174,59894,12690,44091,24686,42784,43284,89589,67291,51793,65590,53690,53387,68189,64190,27191,69795,77692,32285,36684,21483,87885,95687,17293,00593,87394,44595,957101,01992,52095,44497,51995,30495,20991,31686,59894,14291,53193,03892,99098,763103,38994,80286,61076,11472,13776,63977,44481,33382,61281,73683,67785,32888,86088,80288,52797,27689,72183,65686,82884,42581,71677,38588,97994,155136,887106,37067,66636,185
       Goodwill 
0
0
22,001
0
4,741
0
4,011
0
3,646
3,464
3,282
4,011
4,011
4,011
4,011
83,265
83,265
83,265
83,265
83,265
83,265
83,265
83,265
87,542
87,542
88,250
88,250
89,294
89,294
89,294
97,301
97,301
97,301
97,301
120,289
118,221
118,355
120,736
120,771
119,584
120,952
114,995
182,114
175,586
182,670
180,105
183,275
180,969
183,789
185,400
364,545
364,835
358,394
364,252
350,474
351,793
394,052
402,128
403,216
402,393
404,806
399,718
408,937
422,562
424,994
421,583
421,610
427,790
430,915
435,619
425,841
442,311
422,241
421,413
403,239
411,717
409,736
411,441
12,994,620
13,111,000
13,461,000
13,696,000
13,874,000
14,025,000
14,552,000
14,244,000
9,591,000
9,867,000
9,867,0009,591,00014,244,00014,552,00014,025,00013,874,00013,696,00013,461,00013,111,00012,994,620411,441409,736411,717403,239421,413422,241442,311425,841435,619430,915427,790421,610421,583424,994422,562408,937399,718404,806402,393403,216402,128394,052351,793350,474364,252358,394364,835364,545185,400183,789180,969183,275180,105182,670175,586182,114114,995120,952119,584120,771120,736118,355118,221120,28997,30197,30197,30197,30189,29489,29489,29488,25088,25087,54287,54283,26583,26583,26583,26583,26583,26583,26583,2654,0114,0114,0114,0113,2823,4643,64604,01104,741022,00100
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,948
8,917
9,162
9,100
9,168
12,706
13,611
18,387
23,602
26,118
30,774
32,414
32,674
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000032,67432,41430,77426,11823,60218,38713,61112,7069,1689,1009,1628,9178,9480000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
25,712
25,527
26,010
30,278
7,841
12,238
6,480
12,160
3,646
3,464
6,563
13,777
15,190
23,429
7,805
110,966
110,838
110,020
92,243
108,210
108,266
107,712
91,569
110,797
111,107
113,242
96,924
117,978
117,734
119,721
105,176
136,803
48,163
54,417
65,323
68,358
76,681
204,005
131,461
205,330
144,634
21,316
33,892
32,376
40,760
37,058
22,982
19,176
18,368
17,136
196,846
187,339
181,957
175,556
165,044
161,926
266,288
261,432
245,871
231,768
221,415
204,929
198,801
264,339
254,046
238,500
306,387
293,777
382,119
371,280
352,417
352,931
329,079
319,669
299,480
295,615
281,676
268,808
4,552,903
4,536,000
4,609,000
4,635,000
4,648,000
4,629,000
4,755,000
4,573,000
4,312,000
4,403,000
4,403,0004,312,0004,573,0004,755,0004,629,0004,648,0004,635,0004,609,0004,536,0004,552,903268,808281,676295,615299,480319,669329,079352,931352,417371,280382,119293,777306,387238,500254,046264,339198,801204,929221,415231,768245,871261,432266,288161,926165,044175,556181,957187,339196,84617,13618,36819,17622,98237,05840,76032,37633,89221,316144,634205,330131,461204,00576,68168,35865,32354,41748,163136,803105,176119,721117,734117,97896,924113,242111,107110,79791,569107,712108,266108,21092,243110,020110,838110,9667,80523,42915,19013,7776,5633,4643,64612,1606,48012,2387,84130,27826,01025,52725,712
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
34,036
31,557
2,565
17,416
18,186
16,924
2,318
11,335
13,687
13,656
3,210
3,225
1,161
1,237
5,444
5,548
5,772
6,189
9,987
11,006
10,597
8,490
9,666
9,371
8,106
8,122
8,948
8,917
9,162
9,100
9,168
12,706
13,611
18,387
23,602
26,118
30,774
32,414
32,673
35,024
43,273
44,814
39,461
40,184
27,202
31,267
49,226
49,000
50,000
36,000
36,000
1,000
1,000
49,000
2,000
4,403,000
4,403,0002,00049,0001,0001,00036,00036,00050,00049,00049,22631,26727,20240,18439,46144,81443,27335,02432,67332,41430,77426,11823,60218,38713,61112,7069,1689,1009,1628,9178,9488,1228,1069,3719,6668,49010,59711,0069,9876,1895,7725,5485,4441,2371,1613,2253,21013,65613,68711,3352,31816,92418,18617,4162,56531,55734,03600000000000000000000000000000000
> Total Liabilities 
29,940
52,648
86,301
70,961
76,070
60,111
40,560
41,649
39,528
36,823
34,964
32,574
36,917
34,428
34,920
63,728
60,232
59,986
50,395
52,720
49,903
50,368
46,076
49,692
54,173
50,258
50,274
47,672
44,237
40,872
47,246
48,699
57,129
60,475
103,055
110,932
119,260
122,762
122,877
123,823
144,491
523,516
183,216
179,948
186,867
162,468
165,208
155,332
162,006
170,096
269,911
218,618
220,079
192,178
214,271
222,555
233,056
233,124
230,107
209,265
213,468
176,507
193,775
218,738
221,269
208,358
201,255
282,941
349,328
364,709
341,059
320,958
315,638
294,616
288,075
333,539
362,780
364,747
4,087,926
3,993,000
3,917,000
3,804,000
3,811,000
3,747,000
3,969,000
3,749,000
3,668,000
3,640,000
3,640,0003,668,0003,749,0003,969,0003,747,0003,811,0003,804,0003,917,0003,993,0004,087,926364,747362,780333,539288,075294,616315,638320,958341,059364,709349,328282,941201,255208,358221,269218,738193,775176,507213,468209,265230,107233,124233,056222,555214,271192,178220,079218,618269,911170,096162,006155,332165,208162,468186,867179,948183,216523,516144,491123,823122,877122,762119,260110,932103,05560,47557,12948,69947,24640,87244,23747,67250,27450,25854,17349,69246,07650,36849,90352,72050,39559,98660,23263,72834,92034,42836,91732,57434,96436,82339,52841,64940,56060,11176,07070,96186,30152,64829,940
   > Total Current Liabilities 
29,940
32,648
44,299
40,551
49,176
38,531
20,994
21,591
19,594
17,363
18,873
15,869
20,228
17,881
19,368
24,591
22,823
23,209
28,574
31,880
31,351
33,396
31,340
36,493
50,334
45,745
46,952
43,389
41,482
39,084
40,053
41,826
51,302
55,451
71,284
76,232
88,083
91,182
61,332
71,060
90,539
474,286
80,168
92,663
111,730
95,280
99,724
100,565
106,353
118,278
159,831
135,093
143,723
126,426
131,396
139,800
124,881
128,385
159,318
141,295
147,575
116,316
134,895
130,401
132,617
120,702
152,275
163,862
191,770
223,092
202,352
180,523
181,878
169,054
177,014
220,844
240,548
245,494
954,326
918,000
748,000
670,000
621,000
596,000
651,000
596,000
557,000
556,000
556,000557,000596,000651,000596,000621,000670,000748,000918,000954,326245,494240,548220,844177,014169,054181,878180,523202,352223,092191,770163,862152,275120,702132,617130,401134,895116,316147,575141,295159,318128,385124,881139,800131,396126,426143,723135,093159,831118,278106,353100,56599,72495,280111,73092,66380,168474,28690,53971,06061,33291,18288,08376,23271,28455,45151,30241,82640,05339,08441,48243,38946,95245,74550,33436,49331,34033,39631,35131,88028,57423,20922,82324,59119,36817,88120,22815,86918,87317,36319,59421,59120,99438,53149,17640,55144,29932,64829,940
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,981
0
10,389
13,012
20,406
29,393
37,947
40,589
5,424
10,653
12,413
399,034
16,825
16,826
17,219
15,526
17,028
16,820
17,166
16,385
25,774
20,060
19,243
12,235
11,876
12,002
12,319
12,601
37,390
34,207
31,518
79
81
85
0
0
0
10,683
13,131
14,175
14,632
15,409
15,147
14,440
13,593
13,302
15,948
15,675
455,673
474,000
305,000
199,000
182,000
148,000
149,000
145,000
147,000
119,000
119,000147,000145,000149,000148,000182,000199,000305,000474,000455,67315,67515,94813,30213,59314,44015,14715,40914,63214,17513,13110,68300085817931,51834,20737,39012,60112,31912,00211,87612,23519,24320,06025,77416,38517,16616,82017,02815,52617,21916,82616,825399,03412,41310,6535,42440,58937,94729,39320,40613,01210,38902,981000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
37,856
34,653
31,950
79
81
85
0
0
0
29,033
33,635
31,072
0
0
0
0
0
0
0
0
428,610
442,000
273,000
169,000
153,000
119,000
113,000
109,000
114,000
84,000
84,000114,000109,000113,000119,000153,000169,000273,000442,000428,6100000000031,07233,63529,03300085817931,95034,65337,8560000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
11,523
0
9,615
0
6,399
0
0
6,563
8,680
5,846
8,635
6,855
7,263
8,931
6,167
8,023
9,170
10,989
9,521
12,372
9,505
10,963
16,817
14,207
23,531
14,544
11,523
13,075
14,697
15,149
16,274
19,642
26,643
19,286
17,380
18,206
19,865
23,743
21,258
18,464
17,444
20,815
16,788
12,030
15,596
17,567
11,106
19,444
22,282
20,436
20,415
17,668
21,749
22,785
21,806
23,272
24,286
24,609
24,274
27,793
30,598
24,876
28,195
26,483
32,085
40,039
36,088
40,517
29,314
30,934
38,850
23,848
25,922
47,601
46,901
45,079
173,081
179,000
187,000
201,000
181,000
174,000
224,000
163,000
171,000
164,000
164,000171,000163,000224,000174,000181,000201,000187,000179,000173,08145,07946,90147,60125,92223,84838,85030,93429,31440,51736,08840,03932,08526,48328,19524,87630,59827,79324,27424,60924,28623,27221,80622,78521,74917,66820,41520,43622,28219,44411,10617,56715,59612,03016,78820,81517,44418,46421,25823,74319,86518,20617,38019,28626,64319,64216,27415,14914,69713,07511,52314,54423,53114,20716,81710,9639,50512,3729,52110,9899,1708,0236,1678,9317,2636,8558,6355,8468,6806,563006,39909,615011,52300
       Other Current Liabilities 
0
0
17,265
0
33,211
0
13,200
0
0
9,405
7,948
7,650
9,003
8,447
9,461
11,016
12,012
10,542
12,851
14,338
15,277
14,471
15,396
19,091
21,658
20,679
20,204
26,628
27,742
22,376
22,375
23,696
24,639
22,797
24,235
27,553
32,756
32,387
36,043
36,664
56,868
56,788
45,899
55,022
77,723
67,724
67,100
66,178
78,081
82,449
111,775
94,597
104,065
96,523
97,771
105,013
90,756
92,512
97,642
82,479
91,783
88,444
104,216
105,440
104,422
94,219
120,190
113,140
142,551
168,400
158,406
134,180
127,881
130,766
137,499
159,941
177,699
184,740
325,572
76,000
256,000
270,000
212,000
274,000
53,000
62,000
187,000
235,000
235,000187,00062,00053,000274,000212,000270,000256,00076,000325,572184,740177,699159,941137,499130,766127,881134,180158,406168,400142,551113,140120,19094,219104,422105,440104,21688,44491,78382,47997,64292,51290,756105,01397,77196,523104,06594,597111,77582,44978,08166,17867,10067,72477,72355,02245,89956,78856,86836,66436,04332,38732,75627,55324,23522,79724,63923,69622,37522,37627,74226,62820,20420,67921,65819,09115,39614,47115,27714,33812,85110,54212,01211,0169,4618,4479,0037,6507,9489,4050013,200033,211017,26500
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,193
0
5,827
5,024
31,771
34,700
31,177
31,580
61,545
52,763
53,952
49,230
103,048
87,285
75,137
67,188
65,484
54,767
55,653
51,818
110,080
83,525
76,356
65,752
82,875
82,755
108,175
104,739
70,789
67,970
65,893
60,191
58,880
88,337
88,652
87,656
48,980
119,079
157,558
141,617
138,707
140,435
133,760
125,562
111,061
112,695
122,232
119,253
3,133,600
3,075,000
3,169,000
3,134,000
3,190,000
3,151,000
3,318,000
3,153,000
3,111,000
3,084,000
3,084,0003,111,0003,153,0003,318,0003,151,0003,190,0003,134,0003,169,0003,075,0003,133,600119,253122,232112,695111,061125,562133,760140,435138,707141,617157,558119,07948,98087,65688,65288,33758,88060,19165,89367,97070,789104,739108,17582,75582,87565,75276,35683,525110,08051,81855,65354,76765,48467,18875,13787,285103,04849,23053,95252,76361,54531,58031,17734,70031,7715,0245,82707,193000000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
52,181
48,810
46,743
55,880
52,609
2,026,821
1,983,000
2,038,000
2,009,000
2,043,000
2,007,000
2,125,000
2,011,000
0
0
002,011,0002,125,0002,007,0002,043,0002,009,0002,038,0001,983,0002,026,82152,60955,88046,74348,81052,1810000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
543
543
0
0
0
0
0
0
0
0
1
0
0
0
2,489
0
0
0
2,285
0
0
0
0
0
850
850
33,735
24,465
27,277
36,590
29,192
22,917
23,872
24,144
23,791
6,303
5,529
5,205
5,191
10,188
9,140
8,395
9,043
9,012
10,302
7,214
7,311
37,120
88,652
87,656
48,980
52,887
91,376
77,280
77,494
81,148
77,869
73,381
62,251
65,952
66,352
66,644
1,106,779
1,092,000
1,131,000
1,125,000
1,147,000
1,144,000
0
0
0
0
00001,144,0001,147,0001,125,0001,131,0001,092,0001,106,77966,64466,35265,95262,25173,38177,86981,14877,49477,28091,37652,88748,98087,65688,65237,1207,3117,21410,3029,0129,0438,3959,14010,1885,1915,2055,5296,30323,79124,14423,87222,91729,19236,59027,27724,46533,735850850000002,2850002,4890001000000005435430000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
66,999
0
0
0
51,772
0
0
0
41,905
0
0
0
36,524
0
0
0
34,111
0
0
0
58,436
0
0
0
0
0
0
0
0
0
00000000058,43600034,11100036,52400041,90500051,77200066,9990000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
86,850
259,574
241,741
221,823
111,400
97,742
143,435
151,406
154,133
155,891
150,574
160,795
169,073
172,299
176,450
216,296
216,149
221,894
220,639
232,641
241,109
245,443
253,384
256,654
263,122
272,469
292,061
303,882
297,475
298,200
311,588
325,007
331,572
327,075
325,676
324,755
321,961
339,278
342,970
349,022
355,858
-29,362
277,791
284,610
291,205
303,198
320,956
340,299
341,694
382,631
700,914
739,970
735,133
798,764
843,151
882,486
893,818
954,117
1,018,055
1,074,054
1,087,045
1,138,129
1,225,857
1,327,995
1,341,974
1,407,781
1,492,914
1,593,568
1,600,108
1,724,250
1,794,023
1,922,499
1,883,653
1,956,346
2,012,570
2,158,713
2,146,647
5,771,466
15,322,175
15,529,000
15,977,000
16,386,000
16,736,000
17,013,000
17,677,000
17,430,000
12,722,000
13,231,000
13,231,00012,722,00017,430,00017,677,00017,013,00016,736,00016,386,00015,977,00015,529,00015,322,1755,771,4662,146,6472,158,7132,012,5701,956,3461,883,6531,922,4991,794,0231,724,2501,600,1081,593,5681,492,9141,407,7811,341,9741,327,9951,225,8571,138,1291,087,0451,074,0541,018,055954,117893,818882,486843,151798,764735,133739,970700,914382,631341,694340,299320,956303,198291,205284,610277,791-29,362355,858349,022342,970339,278321,961324,755325,676327,075331,572325,007311,588298,200297,475303,882292,061272,469263,122256,654253,384245,443241,109232,641220,639221,894216,149216,296176,450172,299169,073160,795150,574155,891154,133151,406143,43597,742111,400221,823241,741259,57486,850
   Common Stock
0
0
18,390
0
18,390
0
18,390
0
0
0
18,390
0
0
0
18,390
216,296
216,149
221,894
19,790
232,641
241,109
245,443
19,800
256,654
263,122
272,469
19,800
19,800
19,944
19,944
19,944
19,944
19,944
19,944
19,944
19,951
19,954
19,954
19,954
19,954
355,007
19,954
20,228
20,228
20,228
20,228
20,228
20,228
20,228
20,228
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
24,112
27,631
27,000
28,000
28,000
28,000
28,000
28,000
28,000
28,000
28,000
28,00028,00028,00028,00028,00028,00028,00028,00027,00027,63124,11222,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14420,22820,22820,22820,22820,22820,22820,22820,22819,954355,00719,95419,95419,95419,95419,95119,94419,94419,94419,94419,94419,94419,94419,80019,800272,469263,122256,65419,800245,443241,109232,64119,790221,894216,149216,29618,39000018,39000018,390018,390018,39000
   Retained Earnings Total Equity0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
595,000
892,000
1,164,000
1,341,000
2,009,000
1,641,000
1,144,000
1,541,000
1,541,0001,144,0001,641,0002,009,0001,341,0001,164,000892,000595,00000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
494,610
494,610
494,610
483,763
494,610
494,610
494,610
4,025,886
13,543,973
13,544,000
13,544,000
13,544,000
13,544,000
13,544,000
13,544,000
13,544,000
0
0
0013,544,00013,544,00013,544,00013,544,00013,544,00013,544,00013,544,00013,543,9734,025,886494,610494,610494,610483,763494,610494,610494,6100000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
190,181
0
0
0
185,116
0
0
0
185,254
0
0
-30,213
183,348
0
0
0
182,138
0
0
0
477,972
0
0
0
469,929
0
0
0
506,569
8,754
6,894
-6,782
507,177
43,344
58,378
49,118
544,864
65,590
69,764
87,200
555,456
604,096
553,625
537,420
496,534
523,731
17,318
4,051,406
13,564,557
13,714,000
13,543,000
13,544,000
13,544,000
13,544,000
13,544,000
13,543,000
13,543,000
13,543,000
13,543,00013,543,00013,543,00013,544,00013,544,00013,544,00013,544,00013,543,00013,714,00013,564,5574,051,40617,318523,731496,534537,420553,625604,096555,45687,20069,76465,590544,86449,11858,37843,344507,177-6,7826,8948,754506,569000469,929000477,972000182,138000183,348-30,21300185,254000185,116000190,181000000000000000000000000000000



Balance Sheet

Currency in SEK. All numbers in thousands.